Skip to main content

SummitTX Capital, L.P.

Position in LLY — ELI LILLY & Co

CIK 2052310 FORT WORTH, TX

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,833,053
-$34,652,863 QoQ
Shares Held
2,362
-93.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,181
of 4,605 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LLY Over Time

Shares Held

Position Value (USD)

Derivatives in LLY

reported options exposure · as of Sep 30, 2025
CallValue
$1,526,000
CallShares
2,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

SummitTX Capital, L.P. holds $15,756,921 across 8 Drug Manufacturers - General names. LLY ranks #2 (18.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 LLY
ELI LILLY & Co
This page
2,362 $2,833,053

All Filings in LLY

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,833,053 2,362
2025-12-31 $37,485,916 34,881
2025-09-30 $1,526,000 2,000
2025-09-30 $1,831,200 2,400
2025-06-30 $5,846,475 7,500
2025-06-30 $16,813,682 21,569
2025-03-31 $5,617,013 6,801